Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

VIR BIOTECHNOLOGY, INC.

(VIR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Evolution of the average Target Price on VIR BIOTECHNOLOGY, INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) VIR BIOTECHNOLOGY, INC.
Analyst Recommendations on VIR BIOTECHNOLOGY, INC.
09/14SVB Securities Starts Vir Biotechnology at Outperform With $40 Price Target
MT
09/09Morgan Stanley Initiates Vir Biotechnology at Underweight With $15 Price Target
MT
05/12HC Wainwright Adjusts Vir Biotechnology Price Target to $125 From $200, Maintains Buy Rati..
MT
03/30HC Wainwright Adjusts Vir Biotechnology's Price Target to $200 From $300, Reiterates Buy R..
MT
03/28Needham Adjusts Vir Biotechnology's Price Target to $45 from $80, Keeps Buy Rating
MT
03/03Baird Upgrades Vir Biotechnology to Neutral From Underperform, Adjusts Price Target to $28..
MT
2021HC Wainwright Adjusts Vir Biotechnology's Price Target to $300 from $200, Keeps Buy Rating
MT
More recommendations
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 19,00 $
Average target price 46,78 $
Spread / Average Target 146%
High Price Target 125,00 $
Spread / Highest target 558%
Low Price Target 15,00 $
Spread / Lowest Target -21,1%
Consensus detail
Consensus revision (last 18 months)